Back to top

Join Us for a Virtual Conversation: The Clinical and Policy Landscape of Marijuana and Youth

Poison Control Centers around the country are fielding a rise in calls related to children’s ingestion of marijuana derived products containing tetrahydrocannabinol (THC).

From young children (ages 0-6) to adolescents, youth are consuming products with very high THC levels. These trends follow the increasing availability and potency of products containing THC. While there is a growing body of evidence on health impacts of THC consumption on youth, keeping pace with the evolving market availability of products is challenging. Research on the implications of marijuana policy on the safety of children is critical, as is the implementation of evidence-based solutions to prevent child injury.  
Join PolicyLab and The Poison Control Center at Children’s Hospital of Philadelphia (CHOP) on June 13 at 11 a.m. ET for “The Clinical and Policy Landscape of Marijuana and Youth,” a virtual conversation with pediatric clinicians, researchers, and experts in substance use treatment, policy, and injury prevention who will discuss research on THC and youth, practice and policy considerations, and a changing landscape. 
Panelists will include:

Jesse Hinckley, MD, PhD, assistant professor at the University of Colorado School of Medicine, and practicing child and adolescent psychiatrist 

Frank P. James, MD, JD, medical director, Substance Use and Addiction Services Program Development in the Department of Child and Adolescent Psychiatry and Behavioral Sciences at CHOP

Kevin Osterhoudt, MD, MSCE, attending physician in CHOP’s emergency department and medical director of The Poison Control Center at CHOP

Terri L. Randall, MD, attending psychiatrist in the Department of Child and Adolescent Psychiatry and Behavioral Sciences at CHOP, and Radha Pennotti, MPH, PolicyLab’s policy and strategy manager (moderators)


Can’t join us live? Visit PolicyLab's YouTube channel on Friday, June 14 for a link to the archived video.